The Evolving Role of Mohs Surgeons in Advancing Management of laBCC
Advertisement
Advertisement
Trending on Dermatology Times
1
The Aesthetic Edge: July 2026
2
Sanofi Discontinues Development of OX40L Inhibitor Amlitelimab in Atopic Dermatitis
3
Tapinarof Simplifies Long-Term Atopic Dermatitis Treatment Regimens
4
BBT001 Bispecific Antibody Demonstrates Fast AD Clearance and Long-Lasting Itch Relief in Phase 1 Trial
5